25 XP   0   0   10

Jiangsu Hengrui Medicine Co Ltd
Buy, Hold or Sell?

Let's analyse Jiangsu Hengrui Medicine Co Ltd together

PenkeI guess you are interested in Jiangsu Hengrui Medicine Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Jiangsu Hengrui Medicine Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Jiangsu Hengrui Medicine Co Ltd

I send you an email if I find something interesting about Jiangsu Hengrui Medicine Co Ltd.

Quick analysis of Jiangsu Hengrui Medicine Co Ltd (30 sec.)










What can you expect buying and holding a share of Jiangsu Hengrui Medicine Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.06
When do you have the money?
1 year
How often do you get paid?
82.5%

What is your share worth?

Current worth
¥6.30
Expected worth in 1 year
¥6.76
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥0.92
Return On Investment
2.0%

For what price can you sell your share?

Current Price per Share
¥46.16
Expected price per share
¥41.22 - ¥49.10
How sure are you?
50%

1. Valuation of Jiangsu Hengrui Medicine Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥46.16

Intrinsic Value Per Share

¥3.04 - ¥10.04

Total Value Per Share

¥9.35 - ¥16.34

2. Growth of Jiangsu Hengrui Medicine Co Ltd (5 min.)




Is Jiangsu Hengrui Medicine Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$5.5b$5b$387.7m7.1%

How much money is Jiangsu Hengrui Medicine Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$145.2m$120.7m$24.5m16.9%
Net Profit Margin18.8%16.3%--

How much money comes from the company's main activities?

3. Financial Health of Jiangsu Hengrui Medicine Co Ltd (5 min.)




What can you expect buying and holding a share of Jiangsu Hengrui Medicine Co Ltd? (5 min.)

Welcome investor! Jiangsu Hengrui Medicine Co Ltd's management wants to use your money to grow the business. In return you get a share of Jiangsu Hengrui Medicine Co Ltd.

What can you expect buying and holding a share of Jiangsu Hengrui Medicine Co Ltd?

First you should know what it really means to hold a share of Jiangsu Hengrui Medicine Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Jiangsu Hengrui Medicine Co Ltd is ¥46.16. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Jiangsu Hengrui Medicine Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Jiangsu Hengrui Medicine Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥6.30. Based on the TTM, the Book Value Change Per Share is ¥0.11 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.10 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.12 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Jiangsu Hengrui Medicine Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.030.1%0.020.1%0.020.0%0.030.1%0.020.0%
Usd Book Value Change Per Share0.020.0%0.020.0%0.010.0%0.020.1%0.020.0%
Usd Dividend Per Share0.000.0%0.020.0%0.020.0%0.020.0%0.010.0%
Usd Total Gains Per Share0.020.0%0.030.1%0.040.1%0.040.1%0.030.1%
Usd Price Per Share6.21-6.01-5.51-8.85-7.89-
Price to Earnings Ratio61.49-63.57-104.66-87.23-108.83-
Price-to-Total Gains Ratio353.96-232.45-174.38-238.38-333.14-
Price to Book Ratio7.13-7.05-6.99-14.27-21.04-
Price-to-Total Gains Ratio353.96-232.45-174.38-238.38-333.14-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share6.374696
Number of shares156
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.02
Usd Book Value Change Per Share0.020.02
Usd Total Gains Per Share0.030.04
Gains per Quarter (156 shares)4.966.26
Gains per Year (156 shares)19.8525.02
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1101010101515
2202030212940
3302950314465
4403970425890
55049905273115
660591106387140
7706813073102165
8817815084117190
9918817094131215
1010198190105146240

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%87.00.00.0100.0%
Book Value Change Per Share3.01.00.075.0%10.02.00.083.3%18.02.00.090.0%38.02.00.095.0%82.05.00.094.3%
Dividend per Share4.00.00.0100.0%11.00.01.091.7%18.00.02.090.0%33.00.07.082.5%73.00.014.083.9%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%86.01.00.098.9%

Fundamentals of Jiangsu Hengrui Medicine Co Ltd

About Jiangsu Hengrui Medicine Co Ltd

Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, develops, manufactures, and commercializes drugs worldwide. The company is developing Camrelizumab, Pyrotinib, Fuzuloparib, Adebrelimab, Rezvilutamide, Famitinib, Dalpiciclib, SHR-1701, SHR-1501, SHR-A1811, SHR1459, Mecapegfilgrastim, Apatinib, Linperlisib, and SHR2554 for oncology indications; SHR4640, Retagliptin, SHR20004, SHR-1209, SHR3824, INS068, SHR7280, and SHR2285 for cardiovascular and metabolism indications. It is also developing SHR0302, Hetrombopag, Vunakizumab, and SHR-1703 for autoimmune indications; SHR0410, Imrecoxib, Remimazolam, and SHR8554 for pain; Oteseconazole and HRS9950 for anti-infection; and SHR8028, SHR8058, SHR-1707, and SHR-1222 for other indications. The company was founded in 1970 and is based in Lianyungang, China.

Fundamental data was last updated by Penke on 2024-04-17 06:29:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Jiangsu Hengrui Medicine Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Jiangsu Hengrui Medicine Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Jiangsu Hengrui Medicine Co Ltd to the Drug Manufacturers - General industry mean.
  • A Net Profit Margin of 19.9% means that ¥0.20 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Jiangsu Hengrui Medicine Co Ltd:

  • The MRQ is 19.9%. The company is making a huge profit. +2
  • The TTM is 18.8%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ19.9%TTM18.8%+1.2%
TTM18.8%YOY16.3%+2.5%
TTM18.8%5Y20.5%-1.7%
5Y20.5%10Y21.5%-1.0%
1.1.2. Return on Assets

Shows how efficient Jiangsu Hengrui Medicine Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Jiangsu Hengrui Medicine Co Ltd to the Drug Manufacturers - General industry mean.
  • 2.7% Return on Assets means that Jiangsu Hengrui Medicine Co Ltd generated ¥0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Jiangsu Hengrui Medicine Co Ltd:

  • The MRQ is 2.7%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.5%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.7%TTM2.5%+0.2%
TTM2.5%YOY2.2%+0.3%
TTM2.5%5Y3.8%-1.3%
5Y3.8%10Y4.3%-0.5%
1.1.3. Return on Equity

Shows how efficient Jiangsu Hengrui Medicine Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Jiangsu Hengrui Medicine Co Ltd to the Drug Manufacturers - General industry mean.
  • 2.9% Return on Equity means Jiangsu Hengrui Medicine Co Ltd generated ¥0.03 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Jiangsu Hengrui Medicine Co Ltd:

  • The MRQ is 2.9%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.7%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.9%TTM2.7%+0.2%
TTM2.7%YOY2.4%+0.3%
TTM2.7%5Y4.3%-1.6%
5Y4.3%10Y4.9%-0.7%

1.2. Operating Efficiency of Jiangsu Hengrui Medicine Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Jiangsu Hengrui Medicine Co Ltd is operating .

  • Measures how much profit Jiangsu Hengrui Medicine Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Jiangsu Hengrui Medicine Co Ltd to the Drug Manufacturers - General industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Jiangsu Hengrui Medicine Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM4.4%-4.4%
TTM4.4%YOY10.7%-6.4%
TTM4.4%5Y17.4%-13.0%
5Y17.4%10Y9.9%+7.5%
1.2.2. Operating Ratio

Measures how efficient Jiangsu Hengrui Medicine Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • An Operation Ratio of 0.93 means that the operating costs are ¥0.93 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Jiangsu Hengrui Medicine Co Ltd:

  • The MRQ is 0.932. The company is less efficient in keeping operating costs low.
  • The TTM is 0.988. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.932TTM0.988-0.056
TTM0.988YOY1.049-0.060
TTM0.9885Y0.943+0.045
5Y0.94310Y0.572+0.371

1.3. Liquidity of Jiangsu Hengrui Medicine Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Jiangsu Hengrui Medicine Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A Current Ratio of 12.53 means the company has ¥12.53 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Jiangsu Hengrui Medicine Co Ltd:

  • The MRQ is 12.526. The company is very able to pay all its short-term debts. +2
  • The TTM is 11.584. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ12.526TTM11.584+0.942
TTM11.584YOY9.872+1.712
TTM11.5845Y9.101+2.483
5Y9.10110Y4.931+4.169
1.3.2. Quick Ratio

Measures if Jiangsu Hengrui Medicine Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Jiangsu Hengrui Medicine Co Ltd to the Drug Manufacturers - General industry mean.
  • A Quick Ratio of 2.39 means the company can pay off ¥2.39 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Jiangsu Hengrui Medicine Co Ltd:

  • The MRQ is 2.386. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.678. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.386TTM2.678-0.292
TTM2.678YOY3.972-1.294
TTM2.6785Y3.804-1.126
5Y3.80410Y3.617+0.187

1.4. Solvency of Jiangsu Hengrui Medicine Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Jiangsu Hengrui Medicine Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Jiangsu Hengrui Medicine Co Ltd to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.06 means that Jiangsu Hengrui Medicine Co Ltd assets are financed with 6.2% credit (debt) and the remaining percentage (100% - 6.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Jiangsu Hengrui Medicine Co Ltd:

  • The MRQ is 0.062. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.071. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.062TTM0.071-0.008
TTM0.071YOY0.086-0.015
TTM0.0715Y0.095-0.025
5Y0.09510Y0.096-0.001
1.4.2. Debt to Equity Ratio

Measures if Jiangsu Hengrui Medicine Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Jiangsu Hengrui Medicine Co Ltd to the Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 6.7% means that company has ¥0.07 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Jiangsu Hengrui Medicine Co Ltd:

  • The MRQ is 0.067. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.077. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.067TTM0.077-0.010
TTM0.077YOY0.095-0.018
TTM0.0775Y0.107-0.030
5Y0.10710Y0.109-0.003

2. Market Valuation of Jiangsu Hengrui Medicine Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Jiangsu Hengrui Medicine Co Ltd generates.

  • Above 15 is considered overpriced but always compare Jiangsu Hengrui Medicine Co Ltd to the Drug Manufacturers - General industry mean.
  • A PE ratio of 61.49 means the investor is paying ¥61.49 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Jiangsu Hengrui Medicine Co Ltd:

  • The EOD is 63.160. Based on the earnings, the company is expensive. -2
  • The MRQ is 61.491. Based on the earnings, the company is expensive. -2
  • The TTM is 63.570. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD63.160MRQ61.491+1.669
MRQ61.491TTM63.570-2.079
TTM63.570YOY104.659-41.089
TTM63.5705Y87.233-23.664
5Y87.23310Y108.833-21.600
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Jiangsu Hengrui Medicine Co Ltd:

  • The EOD is 70.220. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 68.364. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is -84.718. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD70.220MRQ68.364+1.856
MRQ68.364TTM-84.718+153.082
TTM-84.718YOY-143.443+58.725
TTM-84.7185Y-52.560-32.158
5Y-52.56010Y33.419-85.979
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Jiangsu Hengrui Medicine Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 7.13 means the investor is paying ¥7.13 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Jiangsu Hengrui Medicine Co Ltd:

  • The EOD is 7.324. Based on the equity, the company is overpriced. -1
  • The MRQ is 7.130. Based on the equity, the company is overpriced. -1
  • The TTM is 7.049. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD7.324MRQ7.130+0.194
MRQ7.130TTM7.049+0.081
TTM7.049YOY6.991+0.058
TTM7.0495Y14.272-7.223
5Y14.27210Y21.040-6.768
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Jiangsu Hengrui Medicine Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1210.114+6%0.102+19%0.169-29%0.133-9%
Book Value Per Share--6.3036.174+2%5.730+10%4.911+28%3.378+87%
Current Ratio--12.52611.584+8%9.872+27%9.101+38%4.931+154%
Debt To Asset Ratio--0.0620.071-12%0.086-27%0.095-35%0.096-35%
Debt To Equity Ratio--0.0670.077-13%0.095-29%0.107-37%0.109-39%
Dividend Per Share--0.0060.117-95%0.157-96%0.121-95%0.073-92%
Eps--0.1830.171+7%0.137+33%0.195-6%0.147+24%
Free Cash Flow Per Share--0.1640.061+169%0.041+304%0.090+84%0.121+36%
Free Cash Flow To Equity Per Share--0.164-0.075+146%-0.030+118%0.023+613%0.087+88%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--10.040--------
Intrinsic Value_10Y_min--3.044--------
Intrinsic Value_1Y_max--0.561--------
Intrinsic Value_1Y_min--0.227--------
Intrinsic Value_3Y_max--2.025--------
Intrinsic Value_3Y_min--0.754--------
Intrinsic Value_5Y_max--3.897--------
Intrinsic Value_5Y_min--1.356--------
Market Cap294454631137.280+3%286672362193.560277789601527.015+3%254929200511.920+12%409297693088.432-30%364460525354.082-21%
Net Profit Margin--0.1990.188+6%0.163+22%0.205-3%0.215-7%
Operating Margin---0.044-100%0.107-100%0.174-100%0.099-100%
Operating Ratio--0.9320.988-6%1.049-11%0.943-1%0.572+63%
Pb Ratio7.324+3%7.1307.049+1%6.991+2%14.272-50%21.040-66%
Pe Ratio63.160+3%61.49163.570-3%104.659-41%87.233-30%108.833-44%
Price Per Share46.160+3%44.94043.548+3%39.930+13%64.109-30%57.107-21%
Price To Free Cash Flow Ratio70.220+3%68.364-84.718+224%-143.443+310%-52.560+177%33.419+105%
Price To Total Gains Ratio363.569+3%353.960232.450+52%174.384+103%238.383+48%333.136+6%
Quick Ratio--2.3862.678-11%3.972-40%3.804-37%3.617-34%
Return On Assets--0.0270.025+10%0.022+25%0.038-28%0.043-37%
Return On Equity--0.0290.027+9%0.024+22%0.043-31%0.049-40%
Total Gains Per Share--0.1270.230-45%0.258-51%0.290-56%0.206-38%
Usd Book Value--5552529545.4205438712595.142+2%5050984933.861+10%4329407247.249+28%2977202391.506+87%
Usd Book Value Change Per Share--0.0170.016+6%0.014+19%0.023-29%0.018-9%
Usd Book Value Per Share--0.8700.853+2%0.791+10%0.678+28%0.466+87%
Usd Dividend Per Share--0.0010.016-95%0.022-96%0.017-95%0.010-92%
Usd Eps--0.0250.024+7%0.019+33%0.027-6%0.020+24%
Usd Free Cash Flow--144773690.30853808152.009+169%35838345.667+304%78888058.293+84%106755899.477+36%
Usd Free Cash Flow Per Share--0.0230.008+169%0.006+304%0.012+84%0.017+36%
Usd Free Cash Flow To Equity Per Share--0.023-0.010+146%-0.004+118%0.003+613%0.012+88%
Usd Market Cap40664184560.058+3%39589453218.93138362743970.881+3%35205722590.696+12%56524011415.512-30%50331998551.399-21%
Usd Price Per Share6.375+3%6.2066.014+3%5.514+13%8.853-30%7.887-21%
Usd Profit--160957497.626145236099.548+11%120713430.734+33%170694366.296-6%129253028.099+25%
Usd Revenue--807229462.567771412702.232+5%747530579.775+8%829820370.986-3%607653443.157+33%
Usd Total Gains Per Share--0.0180.032-45%0.036-51%0.040-56%0.028-38%
 EOD+4 -4MRQTTM+26 -9YOY+26 -95Y+16 -1910Y+19 -16

3.2. Fundamental Score

Let's check the fundamental score of Jiangsu Hengrui Medicine Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1563.160
Price to Book Ratio (EOD)Between0-17.324
Net Profit Margin (MRQ)Greater than00.199
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.386
Current Ratio (MRQ)Greater than112.526
Debt to Asset Ratio (MRQ)Less than10.062
Debt to Equity Ratio (MRQ)Less than10.067
Return on Equity (MRQ)Greater than0.150.029
Return on Assets (MRQ)Greater than0.050.027
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Jiangsu Hengrui Medicine Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5059.559
Ma 20Greater thanMa 5044.554
Ma 50Greater thanMa 10044.359
Ma 100Greater thanMa 20043.533
OpenGreater thanClose46.390
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets42,871,391
Total Liabilities2,664,805
Total Stockholder Equity39,636,901
 As reported
Total Liabilities 2,664,805
Total Stockholder Equity+ 39,636,901
Total Assets = 42,871,391

Assets

Total Assets42,871,391
Total Current Assets30,628,113
Long-term Assets12,243,278
Total Current Assets
Cash And Cash Equivalents 17,405,891
Short-term Investments 209,537
Net Receivables 5,625,150
Inventory 2,478,936
Other Current Assets 265,840
Total Current Assets  (as reported)30,628,113
Total Current Assets  (calculated)25,985,353
+/- 4,642,760
Long-term Assets
Property Plant Equipment 6,701,769
Intangible Assets 3,125,599
Long-term Assets Other 416,073
Long-term Assets  (as reported)12,243,278
Long-term Assets  (calculated)10,243,441
+/- 1,999,837

Liabilities & Shareholders' Equity

Total Current Liabilities2,445,151
Long-term Liabilities219,654
Total Stockholder Equity39,636,901
Total Current Liabilities
Short Long Term Debt 16,100
Accounts payable 1,664,657
Other Current Liabilities 12,569
Total Current Liabilities  (as reported)2,445,151
Total Current Liabilities  (calculated)1,693,326
+/- 751,825
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt73,780
Long-term Liabilities  (as reported)219,654
Long-term Liabilities  (calculated)73,780
+/- 145,874
Total Stockholder Equity
Retained Earnings 27,974,361
Total Stockholder Equity (as reported)39,636,901
Total Stockholder Equity (calculated)27,974,361
+/- 11,662,540
Other
Capital Stock6,379,002
Common Stock Shares Outstanding 6,379,002
Net Invested Capital 39,653,001
Net Working Capital 28,182,962
Property Plant and Equipment Gross 6,701,769



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-06-302000-12-312000-06-30
> Total Assets 
445,883
986,273
1,045,154
1,119,024
1,178,206
1,178,274
1,177,359
1,204,576
1,292,018
1,404,184
1,421,297
1,450,687
1,324,314
1,250,022
1,164,027
1,255,382
1,260,664
1,214,613
1,248,805
1,285,214
1,355,885
1,379,089
1,408,963
1,457,972
1,583,741
1,647,921
1,814,356
2,013,689
1,993,436
2,046,423
2,137,216
2,254,364
2,513,235
2,605,281
2,739,535
2,998,870
3,300,930
3,451,866
3,627,624
3,895,635
4,187,183
4,412,254
4,723,839
4,818,023
5,303,438
5,356,074
5,616,482
5,892,509
6,358,170
6,596,498
7,011,111
7,220,266
7,683,548
8,165,009
8,622,837
9,086,861
9,768,875
10,236,950
10,888,550
11,496,700
12,204,628
12,732,784
13,632,053
14,330,059
15,302,433
15,734,596
16,535,582
18,039,385
18,902,239
20,064,636
20,801,332
22,361,230
23,181,490
24,411,927
25,952,860
27,556,475
29,166,504
29,677,473
32,535,474
34,729,590
36,157,171
37,000,499
38,950,348
39,266,222
39,817,549
40,745,926
40,175,042
42,355,009
42,293,830
41,961,333
42,871,391
42,871,39141,961,33342,293,83042,355,00940,175,04240,745,92639,817,54939,266,22238,950,34837,000,49936,157,17134,729,59032,535,47429,677,47329,166,50427,556,47525,952,86024,411,92723,181,49022,361,23020,801,33220,064,63618,902,23918,039,38516,535,58215,734,59615,302,43314,330,05913,632,05312,732,78412,204,62811,496,70010,888,55010,236,9509,768,8759,086,8618,622,8378,165,0097,683,5487,220,2667,011,1116,596,4986,358,1705,892,5095,616,4825,356,0745,303,4384,818,0234,723,8394,412,2544,187,1833,895,6353,627,6243,451,8663,300,9302,998,8702,739,5352,605,2812,513,2352,254,3642,137,2162,046,4231,993,4362,013,6891,814,3561,647,9211,583,7411,457,9721,408,9631,379,0891,355,8851,285,2141,248,8051,214,6131,260,6641,255,3821,164,0271,250,0221,324,3141,450,6871,421,2971,404,1841,292,0181,204,5761,177,3591,178,2741,178,2061,119,0241,045,154986,273445,883
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,425,682
16,965,906
18,069,392
18,959,392
20,038,014
21,512,153
22,311,305
23,818,984
23,777,926
25,569,303
28,050,036
29,240,658
29,583,551
30,358,167
30,187,749
30,492,980
30,902,701
29,615,954
30,934,054
30,650,444
29,890,954
30,628,113
30,628,11329,890,95430,650,44430,934,05429,615,95430,902,70130,492,98030,187,74930,358,16729,583,55129,240,65828,050,03625,569,30323,777,92623,818,98422,311,30521,512,15320,038,01418,959,39218,069,39216,965,90616,425,682000000000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,526,298
4,561,418
3,889,711
4,266,505
4,348,445
3,956,571
5,043,646
8,769,522
9,562,883
11,050,932
10,804,668
12,571,194
12,509,366
14,333,777
13,630,820
13,605,730
13,420,427
16,000,042
15,110,681
14,233,591
16,137,972
17,405,891
17,405,89116,137,97214,233,59115,110,68116,000,04213,420,42713,605,73013,630,82014,333,77712,509,36612,571,19410,804,66811,050,9329,562,8838,769,5225,043,6463,956,5714,348,4454,266,5053,889,7114,561,4183,526,298000000000000000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,175,190
0
7,063,000
128,302
7,449,416
8,982,672
8,519,802
6,236,281
5,843,177
4,673,111
5,628,004
3,771,774
4,139,825
3,363,343
5,090,351
4,405,186
5,081,580
2,052,391
2,760,494
1,744,251
821,533
209,537
209,537821,5331,744,2512,760,4942,052,3915,081,5804,405,1865,090,3513,363,3434,139,8253,771,7745,628,0044,673,1115,843,1776,236,2818,519,8028,982,6727,449,416128,3027,063,00006,175,190000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
164,284
197,260
250,152
291,917
340,925
309,884
311,466
324,353
369,623
385,378
404,856
384,348
536,681
309,458
314,314
325,767
359,050
304,246
288,990
290,841
322,603
300,724
289,061
265,357
286,390
295,411
353,126
528,006
614,051
679,488
777,027
889,414
791,246
865,612
1,041,292
1,233,909
1,480,422
1,535,434
1,643,753
1,726,378
1,954,748
2,040,233
2,180,836
2,173,135
2,491,344
2,404,202
2,488,133
2,491,833
2,601,517
2,676,080
2,771,861
2,608,896
2,853,006
2,881,229
2,976,466
2,987,292
3,337,094
3,175,967
3,442,109
3,471,635
3,542,690
3,577,870
3,818,942
3,795,229
4,051,983
4,229,645
4,104,162
4,437,385
4,770,687
5,240,093
4,858,052
5,445,513
3,843,567
4,237,411
5,418,869
6,416,852
6,166,089
5,599,674
7,372,079
8,826,877
9,590,491
9,180,702
9,159,111
7,541,931
8,311,501
8,697,138
8,171,478
5,891,397
5,708,772
5,985,763
5,625,150
5,625,1505,985,7635,708,7725,891,3978,171,4788,697,1388,311,5017,541,9319,159,1119,180,7029,590,4918,826,8777,372,0795,599,6746,166,0896,416,8525,418,8694,237,4113,843,5675,445,5134,858,0525,240,0934,770,6874,437,3854,104,1624,229,6454,051,9833,795,2293,818,9423,577,8703,542,6903,471,6353,442,1093,175,9673,337,0942,987,2922,976,4662,881,2292,853,0062,608,8962,771,8612,676,0802,601,5172,491,8332,488,1332,404,2022,491,3442,173,1352,180,8362,040,2331,954,7481,726,3781,643,7531,535,4341,480,4221,233,9091,041,292865,612791,246889,414777,027679,488614,051528,006353,126295,411286,390265,357289,061300,724322,603290,841288,990304,246359,050325,767314,314309,458536,681384,348404,856385,378369,623324,353311,466309,884340,925291,917250,152197,260164,284
       Other Current Assets 
21,736
8,601
10,201
39,231
0
30,437
21,817
16,845
3,289
38,104
12,146
37,346
10,251
46,195
11,286
6,258
6,214
6,981
8,887
9,525
10,974
8,502
9,118
4,839
5,633
6,523
10,999
8,362
4,960
19,244
23,334
36,402
49,729
37,599
42,677
30,112
32,140
7,677
73,365
93,847
163,702
211,458
305,839
308,634
377,497
333,601
324,337
354,594
299,456
378,918
313,835
203,873
211,808
191,352
210,862
212,706
163,990
260,811
226,533
250,632
267,411
322,805
353,267
519,087
1,478,670
504,127
4,763,792
424,152
5,260,942
566,174
6,555,615
640,594
6,773,604
180,486
36,365
724,199
902,182
835,593
736,333
602,253
1,265,345
1,103,446
1,212,340
1,090,403
1,555,480
1,003,557
1,087,182
653,864
520,974
1,322,452
265,840
265,8401,322,452520,974653,8641,087,1821,003,5571,555,4801,090,4031,212,3401,103,4461,265,345602,253736,333835,593902,182724,19936,365180,4866,773,604640,5946,555,615566,1745,260,942424,1524,763,792504,1271,478,670519,087353,267322,805267,411250,632226,533260,811163,990212,706210,862191,352211,808203,873313,835378,918299,456354,594324,337333,601377,497308,634305,839211,458163,70293,84773,3657,67732,14030,11242,67737,59949,72936,40223,33419,2444,9608,36210,9996,5235,6334,8399,1188,50210,9749,5258,8876,9816,2146,25811,28646,19510,25137,34612,14638,1043,28916,84521,81730,437039,23110,2018,60121,736
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,222,099
4,373,913
4,440,708
5,245,171
5,347,520
5,899,547
6,966,171
6,679,554
6,916,513
7,416,948
8,592,181
9,078,473
9,324,569
9,843,224
10,559,088
11,420,955
11,643,386
12,070,380
12,243,278
12,243,27812,070,38011,643,38611,420,95510,559,0889,843,2249,324,5699,078,4738,592,1817,416,9486,916,5136,679,5546,966,1715,899,5475,347,5205,245,1714,440,7084,373,9134,222,099000000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
131,582
195,167
230,808
420,491
432,889
511,115
516,223
548,793
571,960
638,758
676,850
692,361
452,325
465,511
451,839
491,121
490,986
480,904
473,299
479,988
491,781
466,449
469,042
508,529
459,842
504,956
479,520
501,252
476,363
513,232
497,680
543,967
514,415
572,979
543,167
609,255
567,808
764,118
668,445
813,150
777,325
893,936
917,461
1,035,785
1,042,704
1,141,776
1,123,952
1,336,276
1,380,242
1,505,060
1,482,226
1,766,440
1,589,479
1,592,549
1,579,693
1,624,179
1,622,579
1,652,271
1,695,444
1,770,200
1,873,903
2,002,008
2,195,975
2,473,942
2,562,174
2,718,958
2,835,101
3,078,754
3,118,653
3,125,236
3,293,871
3,686,018
3,630,568
3,662,750
3,674,776
4,074,800
4,065,147
4,163,744
4,293,260
4,585,239
4,791,420
5,256,213
5,763,881
6,275,603
6,455,504
6,432,849
6,583,053
6,675,738
6,649,849
6,688,104
6,701,769
6,701,7696,688,1046,649,8496,675,7386,583,0536,432,8496,455,5046,275,6035,763,8815,256,2134,791,4204,585,2394,293,2604,163,7444,065,1474,074,8003,674,7763,662,7503,630,5683,686,0183,293,8713,125,2363,118,6533,078,7542,835,1012,718,9582,562,1742,473,9422,195,9752,002,0081,873,9031,770,2001,695,4441,652,2711,622,5791,624,1791,579,6931,592,5491,589,4791,766,4401,482,2261,505,0601,380,2421,336,2761,123,9521,141,7761,042,7041,035,785917,461893,936777,325813,150668,445764,118567,808609,255543,167572,979514,415543,967497,680513,232476,363501,252479,520504,956459,842508,529469,042466,449491,781479,988473,299480,904490,986491,121451,839465,511452,325692,361676,850638,758571,960548,793516,223511,115432,889420,491230,808195,167131,582
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
132,563
149,351
155,650
96,684
175,577
181,084
599,428
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000599,428181,084175,57796,684155,650149,351132,563000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
2,157
12,809
13,432
13,372
14,364
14,695
11,668
12,458
13,565
13,438
13,650
13,121
657
785
393
393
0
0
0
0
0
28,678
35
28,368
32
29,807
29,583
29,477
0
40,426
0
39,960
50,278
50,045
109,799
112,572
52,337
52,089
51,841
51,593
51,345
51,063
50,815
50,567
66,895
67,121
66,640
193,362
202,674
201,594
200,514
199,433
199,876
198,111
197,882
197,004
195,847
198,758
287,895
286,512
284,716
284,145
282,509
281,203
279,256
277,568
275,992
273,699
272,682
271,044
83
352,254
349,762
347,515
345,269
343,025
341,253
338,979
328,143
437,678
702,437
1,155,290
1,475,858
1,845,449
2,200,929
2,474,737
2,921,537
3,125,599
3,125,5992,921,5372,474,7372,200,9291,845,4491,475,8581,155,290702,437437,678328,143338,979341,253343,025345,269347,515349,762352,25483271,044272,682273,699275,992277,568279,256281,203282,509284,145284,716286,512287,895198,758195,847197,004197,882198,111199,876199,433200,514201,594202,674193,36266,64067,12166,89550,56750,81551,06351,34551,59351,84152,08952,337112,572109,79950,04550,27839,960040,426029,47729,58329,8073228,3683528,6780000039339378565713,12113,65013,43813,56512,45811,66814,69514,36413,37213,43212,8092,157000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
36,684
115,577
121,084
539,428
651,613
1,106,478
4,293,260
0
0
0
43,000
648,994
602,178
636,509
558,058
442,550
431,429
423,699
416,073
416,073423,699431,429442,550558,058636,509602,178648,99443,0000004,293,2601,106,478651,613539,428121,084115,57736,684000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
257,635
313,706
329,424
361,034
398,178
365,363
347,658
394,602
458,284
561,178
550,629
547,337
392,747
321,946
194,185
257,329
275,366
192,716
172,163
177,104
197,678
220,516
202,473
201,074
295,058
277,017
342,890
380,508
283,877
266,244
270,216
229,914
270,500
248,704
274,402
333,852
488,922
444,983
337,932
420,802
433,797
492,375
579,984
439,471
602,089
478,477
472,674
450,011
569,132
574,353
693,816
564,396
627,842
718,568
783,574
796,983
897,964
953,052
1,073,951
1,138,935
1,152,185
1,233,993
1,450,927
1,455,667
1,617,492
1,555,498
1,551,150
2,096,170
1,907,223
2,382,901
2,154,494
2,563,491
2,685,715
2,573,046
2,697,703
2,618,948
2,898,357
2,964,838
4,130,230
3,942,588
3,685,280
3,622,879
4,131,025
3,694,414
3,034,769
4,110,887
2,865,322
3,941,853
2,819,746
2,525,468
2,664,805
2,664,8052,525,4682,819,7463,941,8532,865,3224,110,8873,034,7693,694,4144,131,0253,622,8793,685,2803,942,5884,130,2302,964,8382,898,3572,618,9482,697,7032,573,0462,685,7152,563,4912,154,4942,382,9011,907,2232,096,1701,551,1501,555,4981,617,4921,455,6671,450,9271,233,9931,152,1851,138,9351,073,951953,052897,964796,983783,574718,568627,842564,396693,816574,353569,132450,011472,674478,477602,089439,471579,984492,375433,797420,802337,932444,983488,922333,852274,402248,704270,500229,914270,216266,244283,877380,508342,890277,017295,058201,074202,473220,516197,678177,104172,163192,716275,366257,329194,185321,946392,747547,337550,629561,178458,284394,602347,658365,363398,178361,034329,424313,706257,635
   > Total Current Liabilities 
215,528
189,898
215,766
241,034
283,977
245,362
241,758
305,102
335,783
442,678
422,129
433,338
286,748
227,947
145,185
237,329
262,365
179,302
119,598
122,691
143,266
164,914
146,721
140,853
247,058
274,733
339,411
355,009
279,020
265,453
270,217
229,914
270,069
248,704
274,402
323,852
478,922
434,983
327,907
400,802
413,797
472,345
559,954
429,471
592,089
468,477
462,674
440,011
559,132
564,353
683,816
554,396
617,842
708,568
773,574
714,530
815,177
859,571
976,998
1,053,159
1,062,614
1,119,468
1,349,794
1,364,875
1,520,011
1,448,839
1,432,558
2,050,399
1,860,648
2,318,379
2,081,932
2,493,634
2,610,906
2,456,189
2,562,724
2,472,635
2,740,845
2,777,183
3,919,358
3,771,593
3,456,275
3,387,876
3,941,047
3,401,532
2,750,768
3,837,531
2,581,254
3,639,220
2,536,713
2,259,969
2,445,151
2,445,1512,259,9692,536,7133,639,2202,581,2543,837,5312,750,7683,401,5323,941,0473,387,8763,456,2753,771,5933,919,3582,777,1832,740,8452,472,6352,562,7242,456,1892,610,9062,493,6342,081,9322,318,3791,860,6482,050,3991,432,5581,448,8391,520,0111,364,8751,349,7941,119,4681,062,6141,053,159976,998859,571815,177714,530773,574708,568617,842554,396683,816564,353559,132440,011462,674468,477592,089429,471559,954472,345413,797400,802327,907434,983478,922323,852274,402248,704270,069229,914270,217265,453279,020355,009339,411274,733247,058140,853146,721164,914143,266122,691119,598179,302262,365237,329145,185227,947286,748433,338422,129442,678335,783305,102241,758245,362283,977241,034215,766189,898215,528
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,260,943
10,000
10,000
16,100
16,10010,00010,0001,260,943000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
50,595
43,591
36,068
40,267
48,777
40,092
31,943
52,587
44,574
78,543
65,214
67,761
52,414
44,741
42,283
66,139
53,237
56,467
50,586
57,767
54,091
43,169
36,418
46,256
58,264
98,261
144,101
125,788
67,491
81,424
61,181
131,967
125,152
128,578
127,498
138,565
125,233
120,959
111,778
196,511
179,407
230,111
259,688
199,622
286,800
249,844
231,334
219,807
249,374
185,450
323,664
289,971
290,782
311,134
362,116
373,285
485,742
462,911
562,991
409,893
592,599
531,126
804,992
755,038
958,644
627,157
765,808
733,694
656,632
1,013,932
778,039
1,188,488
1,279,638
1,453,352
1,350,791
1,058,939
1,393,744
1,366,160
1,481,507
1,432,734
1,145,518
1,527,662
1,892,530
1,920,217
2,054,501
1,419,691
1,713,929
1,767,549
1,883,704
1,309,383
1,664,657
1,664,6571,309,3831,883,7041,767,5491,713,9291,419,6912,054,5011,920,2171,892,5301,527,6621,145,5181,432,7341,481,5071,366,1601,393,7441,058,9391,350,7911,453,3521,279,6381,188,488778,0391,013,932656,632733,694765,808627,157958,644755,038804,992531,126592,599409,893562,991462,911485,742373,285362,116311,134290,782289,971323,664185,450249,374219,807231,334249,844286,800199,622259,688230,111179,407196,511111,778120,959125,233138,565127,498128,578125,152131,96761,18181,42467,491125,788144,10198,26158,26446,25636,41843,16954,09157,76750,58656,46753,23766,13942,28344,74152,41467,76165,21478,54344,57452,58731,94340,09248,77740,26736,06843,59150,595
       Other Current Liabilities 
58,743
84,427
74,518
68,867
66,500
64,070
45,015
85,515
71,709
91,198
99,277
99,506
84,334
69,606
63,902
92,190
159,128
105,835
69,012
64,924
89,175
121,745
110,303
94,597
188,794
116,472
135,310
169,221
211,529
184,029
209,036
97,947
144,917
120,126
146,904
185,287
353,689
314,024
216,129
204,291
234,390
242,234
300,266
219,849
295,289
208,633
231,340
220,204
309,758
378,903
360,152
254,425
317,060
387,434
401,458
341,245
329,434
396,661
414,007
633,235
459,986
578,312
534,773
609,837
561,367
821,682
666,751
1,316,705
1,204,016
1,192,957
1,303,893
1,239,519
1,331,134
1,135,164
1,209,673
1,228,403
1,338,479
1,211,214
2,434,551
2,208,317
2,307,029
1,768,912
2,047,769
1,315,658
695,694
1,733,113
865,880
11,378
10,572
727,716
12,569
12,569727,71610,57211,378865,8801,733,113695,6941,315,6582,047,7691,768,9122,307,0292,208,3172,434,5511,211,2141,338,4791,228,4031,209,6731,135,1641,331,1341,239,5191,303,8931,192,9571,204,0161,316,705666,751821,682561,367609,837534,773578,312459,986633,235414,007396,661329,434341,245401,458387,434317,060254,425360,152378,903309,758220,204231,340208,633295,289219,849300,266242,234234,390204,291216,129314,024353,689185,287146,904120,126144,91797,947209,036184,029211,529169,221135,310116,472188,79494,597110,303121,74589,17564,92469,012105,835159,12892,19063,90269,60684,33499,50699,27791,19871,70985,51545,01564,07066,50068,86774,51884,42758,743
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
74,809
116,857
134,979
146,313
157,511
187,655
210,871
170,995
229,005
235,003
189,978
292,881
284,001
273,356
284,068
302,633
283,033
265,499
219,654
219,654265,499283,033302,633284,068273,356284,001292,881189,978235,003229,005170,995210,871187,655157,511146,313134,979116,85774,809000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
3,008
3,658
0
1
1
0
0
1
0
0
0
0
0
0
0
1
4,414
4,565
6,413
6,412
7,602
7,752
12,221
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
72,453
72,788
83,481
86,953
85,777
89,571
114,525
101,133
90,792
97,481
106,659
118,592
45,771
46,575
64,522
72,562
69,857
74,809
116,857
134,979
146,313
157,511
187,655
210,871
170,995
181,830
183,210
140,008
141,292
140,251
141,683
136,792
0
0
0
0
0000136,792141,683140,251141,292140,008183,210181,830170,995210,871187,655157,511146,313134,979116,85774,80969,85772,56264,52246,57545,771118,592106,65997,48190,792101,133114,52589,57185,77786,95383,48172,78872,453000000000000000000000000000000012,2217,7527,6026,4126,4134,5654,414100000001001103,6583,0080
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,113
14,851
65,481
98,845
116,203
126,871
155,091
151,695
158,152
174,321
197,632
200,740
241,345
266,810
569,376
1,011,702
1,242,564
1,601,918
0
0
0
0
00001,601,9181,242,5641,011,702569,376266,810241,345200,740197,632174,321158,152151,695155,091126,871116,20398,84565,48114,8517,113000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
185,987
670,433
713,277
743,062
762,275
787,015
801,890
792,100
814,656
827,602
853,623
886,660
917,610
912,558
951,842
983,774
972,573
1,009,114
1,062,640
1,094,981
1,146,265
1,146,383
1,194,881
1,245,513
1,276,201
1,356,537
1,452,241
1,615,703
1,689,991
1,757,839
1,840,582
1,994,375
2,207,087
2,315,783
2,415,466
2,607,735
2,748,984
2,937,363
3,213,766
3,387,376
3,654,187
3,805,405
4,014,702
4,224,177
4,530,953
4,689,889
4,939,047
5,214,102
5,552,688
5,761,029
6,044,859
6,357,231
6,747,606
7,123,973
7,500,804
7,934,392
8,504,535
8,885,331
9,407,382
9,931,365
10,627,218
11,066,190
11,723,927
12,387,954
13,202,681
13,659,302
14,428,722
15,367,821
16,396,217
17,071,820
18,555,091
19,728,178
20,425,193
21,768,522
23,153,224
24,775,325
26,115,208
26,546,910
28,246,291
30,504,303
32,189,398
32,785,699
34,237,398
35,002,961
36,242,720
36,068,116
36,753,048
37,823,808
38,891,810
38,860,607
39,636,901
39,636,90138,860,60738,891,81037,823,80836,753,04836,068,11636,242,72035,002,96134,237,39832,785,69932,189,39830,504,30328,246,29126,546,91026,115,20824,775,32523,153,22421,768,52220,425,19319,728,17818,555,09117,071,82016,396,21715,367,82114,428,72213,659,30213,202,68112,387,95411,723,92711,066,19010,627,2189,931,3659,407,3828,885,3318,504,5357,934,3927,500,8047,123,9736,747,6066,357,2316,044,8595,761,0295,552,6885,214,1024,939,0474,689,8894,530,9534,224,1774,014,7023,805,4053,654,1873,387,3763,213,7662,937,3632,748,9842,607,7352,415,4662,315,7832,207,0871,994,3751,840,5821,757,8391,689,9911,615,7031,452,2411,356,5371,276,2011,245,5131,194,8811,146,3831,146,2651,094,9811,062,6401,009,114972,573983,774951,842912,558917,610886,660853,623827,602814,656792,100801,890787,015762,275743,062713,277670,433185,987
   Common Stock
92,850
132,850
212,560
212,560
212,560
255,072
255,072
255,072
255,072
255,072
255,072
255,072
255,072
255,072
255,072
255,072
255,072
255,072
255,072
255,072
255,072
255,072
331,594
331,594
431,072
431,072
431,072
431,072
431,072
517,286
517,286
517,286
517,286
620,743
620,743
620,743
744,892
744,892
749,433
749,433
749,433
1,124,150
1,124,150
1,124,150
1,124,150
1,236,565
1,236,565
1,236,565
1,236,565
1,360,221
1,360,221
1,360,221
1,360,221
1,503,993
1,503,993
1,505,016
1,505,016
1,956,499
1,956,499
1,956,499
1,956,469
2,347,763
2,347,763
2,347,460
2,347,460
2,816,890
2,816,883
2,832,648
2,832,648
3,682,442
3,682,442
3,685,862
4,423,034
4,422,814
4,422,814
4,422,814
4,422,814
5,306,750
5,306,750
5,331,717
5,331,717
6,397,478
6,397,478
6,396,012
6,379,002
6,379,002
6,379,002
0
0
0
0
00006,379,0026,379,0026,379,0026,396,0126,397,4786,397,4785,331,7175,331,7175,306,7505,306,7504,422,8144,422,8144,422,8144,422,8144,423,0343,685,8623,682,4423,682,4422,832,6482,832,6482,816,8832,816,8902,347,4602,347,4602,347,7632,347,7631,956,4691,956,4991,956,4991,956,4991,505,0161,505,0161,503,9931,503,9931,360,2211,360,2211,360,2211,360,2211,236,5651,236,5651,236,5651,236,5651,124,1501,124,1501,124,1501,124,150749,433749,433749,433744,892744,892620,743620,743620,743517,286517,286517,286517,286431,072431,072431,072431,072431,072331,594331,594255,072255,072255,072255,072255,072255,072255,072255,072255,072255,072255,072255,072255,072255,072255,072255,072255,072212,560212,560212,560132,85092,850
   Retained Earnings 
61,204
64,945
67,935
85,011
103,234
85,152
100,027
74,537
97,093
110,039
136,059
149,900
182,771
177,719
217,003
224,411
213,210
249,751
303,277
247,058
298,342
354,576
403,074
433,041
364,399
444,735
540,439
662,377
736,664
720,733
803,446
909,890
1,122,601
1,127,812
1,227,495
1,352,705
1,369,805
1,557,985
1,730,102
1,822,330
2,076,694
1,990,177
2,194,251
2,334,547
2,636,491
2,678,171
2,925,243
3,110,248
3,446,898
3,529,676
3,813,321
4,019,251
5,056,892
5,168,575
5,525,435
5,924,062
6,471,432
6,533,800
7,044,198
7,644,134
8,328,473
8,371,515
8,985,785
9,646,145
10,457,993
10,433,177
11,187,512
12,076,394
13,025,846
13,051,388
14,451,220
15,207,230
12,759,555
14,083,090
15,413,982
19,102,848
20,418,274
19,863,180
21,459,855
23,529,646
25,026,193
24,064,748
25,604,354
25,927,859
27,164,809
27,032,395
28,086,268
25,520,455
26,759,563
26,808,847
27,974,361
27,974,36126,808,84726,759,56325,520,45528,086,26827,032,39527,164,80925,927,85925,604,35424,064,74825,026,19323,529,64621,459,85519,863,18020,418,27419,102,84815,413,98214,083,09012,759,55515,207,23014,451,22013,051,38813,025,84612,076,39411,187,51210,433,17710,457,9939,646,1458,985,7858,371,5158,328,4737,644,1347,044,1986,533,8006,471,4325,924,0625,525,4355,168,5755,056,8924,019,2513,813,3213,529,6763,446,8983,110,2482,925,2432,678,1712,636,4912,334,5472,194,2511,990,1772,076,6941,822,3301,730,1021,557,9851,369,8051,352,7051,227,4951,127,8121,122,601909,890803,446720,733736,664662,377540,439444,735364,399433,041403,074354,576298,342247,058303,277249,751213,210224,411217,003177,719182,771149,900136,059110,03997,09374,537100,02785,152103,23485,01167,93564,94561,204
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000-523,713-523,713-523,713-528,473-4,760-38,157-43,428-43,428-45,932-81,125-81,125-87,83000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-2,983
-1,395
-9,645
-11,350
2,429
3,217
6,531
11,693
10,692
59
-4,793
-2,277
-4,831
-5,505
-12,159
-12,185
-16,777
-19,618
0
0
0
0
0000-19,618-16,777-12,185-12,159-5,505-4,831-2,277-4,7935910,69211,6936,5313,2172,429-11,350-9,645-1,395-2,983000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue22,343,597
Cost of Revenue-3,475,445
Gross Profit18,868,15318,868,153
 
Operating Income (+$)
Gross Profit18,868,153
Operating Expense-18,563,249
Operating Income3,780,349304,904
 
Operating Expense (+$)
Research Development5,114,509
Selling General Administrative9,553,139
Selling And Marketing Expenses-
Operating Expense18,563,24914,667,648
 
Net Interest Income (+$)
Interest Income283,082
Interest Expense-9,179
Other Finance Cost-104,204
Net Interest Income378,106
 
Pretax Income (+$)
Operating Income3,780,349
Net Interest Income378,106
Other Non-Operating Income Expenses-
Income Before Tax (EBT)4,246,8763,780,349
EBIT - interestExpense = -9,179
4,206,694
4,215,873
Interest Expense9,179
Earnings Before Interest and Taxes (EBIT)-4,256,055
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax4,246,876
Tax Provision-76,822
Net Income From Continuing Ops4,170,0544,170,054
Net Income4,206,694
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--378,106
 

Technical Analysis of Jiangsu Hengrui Medicine Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Jiangsu Hengrui Medicine Co Ltd. The general trend of Jiangsu Hengrui Medicine Co Ltd is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Jiangsu Hengrui Medicine Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Jiangsu Hengrui Medicine Co Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 46.86 < 48.53 < 49.10.

The bearish price targets are: 45.50 > 41.60 > 41.22.

Tweet this
Jiangsu Hengrui Medicine Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Jiangsu Hengrui Medicine Co Ltd. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Jiangsu Hengrui Medicine Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Jiangsu Hengrui Medicine Co Ltd. The current macd is 0.1439576.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Jiangsu Hengrui Medicine Co Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Jiangsu Hengrui Medicine Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Jiangsu Hengrui Medicine Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Jiangsu Hengrui Medicine Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartJiangsu Hengrui Medicine Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Jiangsu Hengrui Medicine Co Ltd. The current adx is 20.14.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Jiangsu Hengrui Medicine Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Jiangsu Hengrui Medicine Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Jiangsu Hengrui Medicine Co Ltd. The current sar is 41.80.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Jiangsu Hengrui Medicine Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Jiangsu Hengrui Medicine Co Ltd. The current rsi is 59.56. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Jiangsu Hengrui Medicine Co Ltd Daily Relative Strength Index (RSI) ChartJiangsu Hengrui Medicine Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Jiangsu Hengrui Medicine Co Ltd. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Jiangsu Hengrui Medicine Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Jiangsu Hengrui Medicine Co Ltd Daily Stochastic Oscillator ChartJiangsu Hengrui Medicine Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Jiangsu Hengrui Medicine Co Ltd. The current cci is 115.66.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Jiangsu Hengrui Medicine Co Ltd Daily Commodity Channel Index (CCI) ChartJiangsu Hengrui Medicine Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Jiangsu Hengrui Medicine Co Ltd. The current cmo is 28.62.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Jiangsu Hengrui Medicine Co Ltd Daily Chande Momentum Oscillator (CMO) ChartJiangsu Hengrui Medicine Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Jiangsu Hengrui Medicine Co Ltd. The current willr is -12.41134752.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Jiangsu Hengrui Medicine Co Ltd Daily Williams %R ChartJiangsu Hengrui Medicine Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Jiangsu Hengrui Medicine Co Ltd.

Jiangsu Hengrui Medicine Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Jiangsu Hengrui Medicine Co Ltd. The current atr is 1.30579205.

Jiangsu Hengrui Medicine Co Ltd Daily Average True Range (ATR) ChartJiangsu Hengrui Medicine Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Jiangsu Hengrui Medicine Co Ltd. The current obv is 1,171,751,750.

Jiangsu Hengrui Medicine Co Ltd Daily On-Balance Volume (OBV) ChartJiangsu Hengrui Medicine Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Jiangsu Hengrui Medicine Co Ltd. The current mfi is 61.82.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Jiangsu Hengrui Medicine Co Ltd Daily Money Flow Index (MFI) ChartJiangsu Hengrui Medicine Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Jiangsu Hengrui Medicine Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-05BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-25STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-31ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-30STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Jiangsu Hengrui Medicine Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Jiangsu Hengrui Medicine Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5059.559
Ma 20Greater thanMa 5044.554
Ma 50Greater thanMa 10044.359
Ma 100Greater thanMa 20043.533
OpenGreater thanClose46.390
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Jiangsu Hengrui Medicine Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Jiangsu Hengrui Medicine Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Jiangsu Hengrui Medicine Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Jiangsu Hengrui Medicine Co Ltd

I send you an email if I find something interesting about Jiangsu Hengrui Medicine Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Jiangsu Hengrui Medicine Co Ltd.

Receive notifications about Jiangsu Hengrui Medicine Co Ltd in your mailbox!